BiotechTube
Home/Immatics Biotechnologies/Edward Sturchio, J.D.
ES

Edward Sturchio, J.D.

General Counsel

Immatics Biotechnologies

Roles

General CounselatImmatics Biotechnologies
General CounselatImmatics

Therapeutic Areas

OncologySolid Tumors

Immatics Biotechnologies Pipeline

DrugIndicationPhase
IMA203PRAME-positive solid tumorsPhase 1/2
IMA203CD8PRAME-positive solid tumorsPhase 1/2
IMA402PRAME-positive solid tumorsPhase 1/2
IMA204Undisclosed solid tumorsPhase 1

Leadership Team at Immatics Biotechnologies

HS
Harpreet Singh, Ph.D.
Chief Executive Officer
CB
Cedrik Britten, M.D.
Chief Medical Officer
CR
Carsten Reinhardt, M.D., Ph.D.
Chief Development Officer
SW
Steffen Walter, Ph.D.
Chief Operating Officer
TW
Toni Weinschenk, Ph.D.
Chief Innovation Officer
VR
Venkat Ramanan, Ph.D.
Chief Financial Officer
RK
Rainer Kramer, Ph.D.
Chief Business Officer & Site Head Munich
PC
Peter Chambré
Chairman of the Board of Directors
HL
Heather L. Mason
Vice Chair of the Board of Directors
View full Immatics Biotechnologies profile